期刊文献+

氯吡格雷对人胃黏膜上皮细胞损伤机制的研究 被引量:9

The study on the mechanim of clopidogrel in human gastric epithelial GES-1 cell line injury
原文传递
导出
摘要 目的探讨氯吡格雷对人胃黏膜上皮细胞(GES-1)的损伤机制。方法建立GES-1单层细胞模型,将细胞分为阴性对照组、U0126干预组、氯吡格雷干预组、联合干预组(U0126预处理后氯吡格雷干预),采用噻唑蓝(MTT)比色法和流式细胞术检测各组细胞增殖、凋亡情况;采用免疫细胞化学法检测各组P-ERK1/2的表达情况;采用Western印迹检测各细胞组p-ERK1/2蛋白的表达量。结果MTT结果显示与朋性对照组相比,U0126干预组、氯吡格雷干预组、联合干预组细胞增殖明显受到抑制,抑制率分别为21.8%±2.7%、46.3%±3.4%、82.9%±0.8%(F=615.556,P=0.000);免疫细胞化学检测结果显示,U0126干预组、氯吡格雷干预组、联合干预组与阴性对照组相比p-ERK表达下降,分别为阴性对照组(10.80±1.64)分、(7.20±1.64)分、U0126干预组(4.40±0.89)分、联合干预组(1.40±0.55)分(F=49.426,P=0.000)。Western印迹检测结果与免疫细胞化学的趋势一致。结论在GES-1细胞模型中,氯吡格雷可能通过MAPK/ERK信号转导通路损伤GES-1细胞。 Objective To explore the mechanism of clopidogrel in human gastric epithelial cell line (GES-1) injury.-Methods Set up GES-1 cells monolayer culture model. Then the GES-1 cells were divided into negative control group, U0126 intervented group, clopidogrel intervented group and combined intervented group (U0126 treated firstly then clopidogrel intervented). The cell proliferation and apoptosis in each group was examined by methyl thiazolyl tetrazolium (MTT) assay and Flow cytometry. The expression of phosphorylated ERK1/2 in each group was detected by immunocytochemistry method, and the expression quantity of phosphorylated ERK1/2 in each group was measured by western blot. Results The result of MTT assay showed that compared with negative control group, the proliferation of GES-1 cells was inhibited in U0126 group, clopidogrel group and combined intervented group, and the inhibition percentage was 21.8 ± 2.7 %, 46.3 ±3.4 % and 82.9% ±0.8%respectively (F= 615. 556, P= 0. 000). The result of immunocytochemistry indicated that the expression of p-ERK in U0126 group, Clopidogrel group and combined intervented group decreased compared with negative control group, which was 10.80±1.64, 7. 20±1.64, 4.40±0.89and 1.40 ± 0.55 respectively (F = 49. 426, P = 0. 000). The result of western blot and immunoeytoehemistry was of the same trend. Conclusion In GES-1 cell model, clopidogrel may injure GES-1 cells through MAPK/ERK signal transduction pathway.
出处 《中华消化杂志》 CAS CSCD 北大核心 2011年第11期724-728,共5页 Chinese Journal of Digestion
基金 南京市医学科技发展专项基金(YKK10107)
关键词 噻氯匹定 信号转导 胃黏膜 上皮细胞 细胞系 Ticlopidine Signal transduction Gastric mucosa~ Epithelial cells Cell line
  • 相关文献

参考文献3

二级参考文献28

  • 1赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 2谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 3Durand-Zaleski I, Bertrand M. The value of clopidogrel versus aspirin in reducing atherothrombotic events: the CAPRIE study. Pharmacoeconomics 2004; 22 Suppl 4: 19-27.
  • 4Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502.
  • 5Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527-533.
  • 6Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288: 2411-2420.
  • 7Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009; 301: 937-944.
  • 8Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, Kopp A, Mamdani MM. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009; 180: 713-718.
  • 9Gilard M, Arnaud B, Le Gal G, Abgrall JF, Boschat J. Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin. J Thromb Haemost 2006; 4: 2508-2509.
  • 10Fontana P, Senouf D, Mach F. Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness. Thromb Res 2008; 121: 463-468.

共引文献1388

同被引文献118

引证文献9

二级引证文献284

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部